Donna Mildvan

13.7k total citations · 3 hit papers
130 papers, 9.6k citations indexed

About

Donna Mildvan is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Donna Mildvan has authored 130 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Infectious Diseases, 58 papers in Epidemiology and 55 papers in Virology. Recurrent topics in Donna Mildvan's work include HIV Research and Treatment (54 papers), HIV/AIDS Research and Interventions (50 papers) and HIV/AIDS drug development and treatment (29 papers). Donna Mildvan is often cited by papers focused on HIV Research and Treatment (54 papers), HIV/AIDS Research and Interventions (50 papers) and HIV/AIDS drug development and treatment (29 papers). Donna Mildvan collaborates with scholars based in United States, Israel and United Kingdom. Donna Mildvan's co-authors include Paul A. Volberding, Oscar L. Laskin, Michael H. Grieco, Margaret A. Fischl, Douglas D. Richman, Michael S. Gottlieb, George Gee Jackson, David T. Durack, John M. Leedom and Jerome E. Groopman and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Donna Mildvan

130 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

1987 2.3k citations Margaret A. Fischl, Donna Mildvan et al. profile →
The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

1987 975 citations Margaret A. Fischl, Donna Mildvan et al. profile →
Acquired Immunodeficiency Syndrome (AIDS) Associated with Transfusions

1984 411 citations Donna Mildvan et al. profile →

Peers

Countries citing papers authored by Donna Mildvan

Since Specialization

Citations

This map shows the geographic impact of Donna Mildvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Mildvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Mildvan more than expected).

Fields of papers citing papers by Donna Mildvan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Mildvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Mildvan. The network helps show where Donna Mildvan may publish in the future.

Co-authorship network of co-authors of Donna Mildvan

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Mildvan. A scholar is included among the top collaborators of Donna Mildvan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Mildvan. Donna Mildvan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibiotic Treatment Failure and Associated Outcomes Among Adult Patients With Community-Acquired Pneumonia in the Outpatient Setting: A Real-world US Insurance Claims Database Study 2020 ·Open Forum Infectious Diseases ·Glenn Tillotson, Thomas P. Lodise, Peter Classi, Donna Mildvan, James A. McKinnell	14
2	HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts 2014 ·Frontiers in Public Health ·Marya Gwadz, Elizabeth Applegate, Charles M. Cleland, Noelle R. Leonard, Hannah Wolfe, Nadim Salomon, (unknown), Marion Riedel, (unknown), (unknown), Andrea Wagner, Donna Mildvan	26
3	Catfish spine envenomation and bacterial abscess with Proteus and Morganella: a case report 2013 ·Journal of Medical Case Reports ·(unknown), Robert M. Goldstein, Donna Mildvan	16
4	Description of an efficacious behavioral peer-driven intervention to reduce racial/ethnic disparities in AIDS clinical trials 2013 ·Health Education Research ·Noelle R. Leonard, (unknown), Marion Riedel, Amanda S. Ritchie, Donna Mildvan, (unknown), Charles M. Cleland, Marya Gwadz	15
5	Predictors of Screening for AIDS Clinical Trials Among African-Americans and Latino/Hispanics Enrolled in an Efficacious Peer-Driven Intervention: Uncovering Socio-Demographic, Health, and Substance Use-Related Factors That Promote or Impede Screening 2012 ·AIDS and Behavior ·Marya Gwadz, Charles M. Cleland, Noelle R. Leonard, Amanda S. Ritchie, (unknown), Marion Riedel, (unknown), Donna Mildvan	9
6	Increasing and Supporting the Participation of Persons of Color Living with HIV/AIDS in AIDS Clinical Trials 2010 ·Current HIV/AIDS Reports ·Marya Gwadz, (unknown), Amanda S. Ritchie, Noelle R. Leonard, Charles M. Cleland, Marion Riedel, (unknown), (unknown), Patricia P. Chang, (unknown), Donna Mildvan	26
7	Attitudes and Perceptions of AIDS Clinical Trials Group Site Coordinators on HIV Clinical Trial Recruitment and Retention: A Descriptive Study 2007 ·AIDS Patient Care and STDs ·William D. King, (unknown), Kimberly Y. Smith, Janet Andersen, (unknown), (unknown), Jennifer A. Mitty, Jan Fritsche, (unknown), (unknown), Margaret A. Fischl, (unknown), Donna Mildvan	24
8	Serum Neopterin, an Immune Activation Marker, Independently Predicts Disease Progression in Advanced HIV-1 Infection 2005 ·Clinical Infectious Diseases ·Donna Mildvan, (unknown), Sidney E. Grossberg, J. L. Fahey, David Johnston, (unknown), Jonathan Kagan	75
9	Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 248) 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mary Vogler, Hedy Teppler, Rebecca Gelman, Fred Valentine, Michael M. Lederman, Roger J. Pomerantz, Richard B. Pollard, (unknown), Charles J. Gonzalez, Kathleen Squires, Ian Frank, Donna Mildvan, (unknown), Barbara Schock	15
10	Once‐Daily versus Twice‐Daily Lopinavir/Ritonavir in Antiretroviral‐Naive HIV‐Positive Patients: A 48‐Week Randomized Clinical Trial 2004 ·The Journal of Infectious Diseases ·Joseph J. Eron, Judith Feinberg, Harold A. Kessler, Harold W. Horowitz, Mallory D. Witt, (unknown), David A. Wheeler, Peter Ruane, Donna Mildvan, Bienvenido G. Yangco, Richard Bertz, Barry Bernstein, Martin King, Eugene Sun	104
11	Implications of Anemia in Human Immunodeficiency Virus, Cancer, and Hepatitis C Virus 2003 ·Clinical Infectious Diseases ·Donna Mildvan	9
12	Can Immune Markers Predict Subsequent Discordance between Immunologic and Virologic Responses to Antiretroviral Therapy? Adult AIDS Clinical Trials Group 2003 ·Clinical Infectious Diseases ·John Spritzler, Donna Mildvan, (unknown), (unknown), Daniella Livnat, Barbara Schock, Jonathan Kagan, Alan Landay, David W. Haas	17
13	Pharmacokinetic Interaction Between Nevirapine and Ethinyl Estradiol/Norethindrone When Administered Concurrently to HIV-Infected Women 2002 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Donna Mildvan, Robert Yarrish, (unknown), (unknown), (unknown), Michael Lamson, Patrick Robinson	64
14	Surrogate Markers: The AIDS Clinical Trials 2000 ·Archives of Neurology ·Donna Mildvan	1
15	Predictive Markers of HIV-Related Weight Loss and Determination of Differences Between Populations With Weight Loss Stratified by Opportunistic Processes 1999 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Robert Zackin, Rebecca A. Clark, Judith S. Currier, Donna Mildvan	7
16	The spectrum of HIV-1-related disease among outpatients in New York City 1992 ·AIDS ·Alan E. Greenberg, P. Thomas, Sheldon H. Landesman, Donna Mildvan, Mindell Seidlin, Gerald Friedland, Robert S. Holzman, (unknown), J. Braun, (unknown), (unknown)	40
17	Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex 1992 ·The Lancet ·Donna Mildvan, Ilene Wilets, Solimar Gonçalves Machado, Sidney E. Grossberg	81
18	Prognostic Significance of Quantitative Levels of HIV p24 Binding Capacity in HIV Infection 1990 ·AIDS Research and Human Retroviruses ·T S Croxson, Usha Mathur‐Wagh, S Handwerger, (unknown), (unknown), K J Reagan, Stanley R. Yancovitz, Donna Mildvan	11
19	Pulmonary infections in the acquired immunodeficiency syndrome. 1986 ·PubMed ·Wilfredo Talavera, Donna Mildvan	9
20	The spectrum and causes of liver diseases in narcotic addicts. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), Donna Mildvan, (unknown)	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact